Purpose
|
I-BET151 (GSK1210151A) is a novel selective BET inhibitor for BRD2, BRD3 and BRD4 with IC50 of 0.5 μM, 0.25 μM, and 0.79 μM in cell-free assays, respectively.
|
Characteristics
|
Target: BET bromodomain inhibitor Receptor: BRD2, BRD3, BRD4
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
98?%
|
Formula
|
C23H21N5O3
|
Solubility
|
10 mM in DMSO
|